Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2025 07:00 ET | Source: Wedbush

Wedbush Securities Enhances Client Offering Through Trading Infrastructure Upgrade with Rapid Addition’s Messaging Platform

Wedbush upgrades trading infrastructure with Rapid Addition’s cloud-ready platform, boosting efficiency, scalability, and multi-asset class capabilities.
June 18, 2025 08:29 ET | Source: Wedbush

Wedbush Securities Expands Trading Leadership with the Hiring of Michael Bower and George Nikitiadis as Managing Directors

Wedbush hires Michael Bower and George Nikitiadis as Managing Directors, bolstering trading leadership and expanding healthcare and program capabilities.
June 17, 2025 08:29 ET | Source: Wedbush

Wedbush Securities and Rival Systems to Offer Seamless Multi-Asset Trading Through Rival One

CHICAGO, June 17, 2025 (GLOBE NEWSWIRE) -- Wedbush Securities, a leading financial services firm, announced today that it is working with Rival Systems, a premier provider of enterprise risk...
June 16, 2025 08:30 ET | Source: Wedbush

Wedbush Financial Services Acquires Minority Interest in Trigon, Establishing a Strategic Partnership to Expand Global Reach and Enhance Client Solutions

Wedbush Financial Services acquires minority stake in Trigon, expanding global reach and enhancing cross-border client solutions and presence across CEE
August 07, 2024 08:00 ET | Source: Compass Therapeutics

Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
August 02, 2022 08:00 ET | Source: Compass Therapeutics

Compass Therapeutics to Present at the 13th Annual Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
August 01, 2022 16:30 ET | Source: Surface Oncology, Inc.

Surface Oncology to Participate in the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
August 05, 2020 16:31 ET | Source: Prevail Therapeutics

Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference

NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with...
August 05, 2020 11:59 ET | Source: Surface Oncology, Inc.

Surface Oncology to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
August 06, 2019 08:33 ET | Source: Aptinyx Inc.

Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference

EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...